Implantable MyoElectric Sensors (IMES) for Prosthetic Control in Transhumeral Amputees
TH-IMES
1 other identifier
interventional
3
0 countries
N/A
Brief Summary
The Implantable Myoelectric Sensors (IMES) system is an investigational device intended to improve signal quality and consistency of myoelectric signals for prosthetic control in individuals suffering from an above elbow (transhumeral) amputation. The sensors pick up myoelectric signals intramuscularly and therefore signal quality is not affected from electrode replacement, perspiration, or artefacts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2014
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedFirst Submitted
Initial submission to the registry
August 11, 2018
CompletedFirst Posted
Study publicly available on registry
August 23, 2018
CompletedAugust 23, 2018
August 1, 2018
3.2 years
August 11, 2018
August 21, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Change in hand function over time
Southampton Hand Assessment Procedure
at 3, 6, 9 and 12 months after final prosthetic fitting
Study Arms (1)
Implantation
OTHERSurgical Implantation of IMES sensors
Interventions
Surgical implantation of IMES sensors during routine surgery to improve prosthetic control
Eligibility Criteria
You may qualify if:
- unilateral transhumeral amputation
- can speak and comprehend German
- undergone amputee rehabilitation, including being trained to wear and use a conventional myoelectric prosthesis
- residual upper limb meets the criterions for TMR surgery
You may not qualify if:
- Known genetic neuromuscular disorder
- bleeding or clotting disorder
- active implant
- any metal fragments or metal implants located within the residual upper limb stump
- Female patients if pregnant or breast-feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY CHAIR
Christian Hofer, PhD
Otto Bock
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Subinvestigator
Study Record Dates
First Submitted
August 11, 2018
First Posted
August 23, 2018
Study Start
August 1, 2014
Primary Completion
October 1, 2017
Study Completion
October 1, 2017
Last Updated
August 23, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share
The study including all results is already submitted to be published